nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Accelerating accessibility of CAR-T/NK therapies – Are AlloCARs and rapid manufacturing platforms the road ahead in improving access in multiple myeloma?
|
Rajeeve, Sridevi |
|
|
61 |
5 |
p. 297-305 |
artikel |
2 |
CARs Moving Forward: The Development of CAR T-Cell Therapy in the Earlier Treatment Course of Hematologic Malignancies
|
Castaneda Puglianini, Omar |
|
|
61 |
5 |
p. 290-296 |
artikel |
3 |
CAR T-cell therapy comes of age: Introductory editorial for the special issue
|
Brudno, Jennifer N. |
|
|
61 |
5 |
p. 271-272 |
artikel |
4 |
Fast and furious: Changing gears on the road to cure with chimeric antigen receptor T cells in multiple myeloma
|
Gagelmann, Nico |
|
|
61 |
5 |
p. 306-313 |
artikel |
5 |
License for a CAR T: Examining patient eligibility
|
Akkad, Neha |
|
|
61 |
5 |
p. 284-289 |
artikel |
6 |
Mobilizing CARs: Benefits, drawbacks, and directions for outpatient CAR T-cell therapy
|
Woo, Jennifer S. |
|
|
61 |
5 |
p. 273-283 |
artikel |
7 |
outside front cover, PMS 8883 metallic AND 4/C
|
|
|
|
61 |
5 |
p. CO1 |
artikel |
8 |
The Road More or Less Traveled- Examining the Role of Consolidative Allogeneic Hematopoietic Stem Cell Transplantation After Chimeric Antigen Receptor T Cell Therapy in B-cell ALL
|
Choe, Michelle |
|
|
61 |
5 |
p. 314-320 |
artikel |
9 |
The winding road: Infectious disease considerations for CAR-T and other novel adoptive cellular therapies in the era of COVID-19
|
Singh, Kanal |
|
|
61 |
5 |
p. 321-332 |
artikel |
10 |
Tuning CAR T-cell therapies for efficacy and reduced toxicity
|
Blud, Danielle |
|
|
61 |
5 |
p. 333-344 |
artikel |